VASCULAR BIOSCIENCES, INC.
DURHAM, United States (US) · Health and Medical
We built this page from public sources.
Do you work at VASCULAR BIOSCIENCES, INC.?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Vascular BioSciences, Inc is a Durham, North Carolina-based biotechnology company specializing in innovative solutions for serious diseases.We develop targeted therapies, including our lead CAR peptide, CARSKNKDC, designed to enhance the efficacy of treatments for pulmonary hypertension, COVID-19, and sepsis.Our core expertise lies in combining interventional technology – exemplified by our world’s first endoarterial biopsy catheter – with advanced molecular diagnostics, offering a comprehensive approach to vascular disease management.
Overview
We develop targeted therapies, including our lead CAR peptide, CARSKNKDC, designed to enhance the efficacy of treatments for pulmonary hypertension, COVID-19, and sepsis.
Our core expertise lies in combining interventional technology – exemplified by our world’s first endoarterial biopsy catheter – with advanced molecular diagnostics, offering a comprehensive approach to vascular disease management. We are dedicated to pioneering disease-selective therapies and improving patient outcomes, driven by a mission to enhance and prolong human life, much like we would care for our own family.
Vascular BioSciences is committed to advancing medical science through groundbreaking research and development, ultimately transforming the landscape of vascular disease treatment.
Contact Details
DURHAM, United States (US)
Employees
2-10
Categories
Products
Companies teams usually look at after VASCULAR BIOSCIENCES, INC.
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.